Granules India update on USFDA inspection at Gagillapur facility
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
The celebrations began with the unveiling of the Biocon Anthem
The 254-bedded Aster Aadhar Hospital, Kolhapur is the city's most comprehensive multi-speciality hospital
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
The product will be marketed by Dr. Reddy's
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
Subscribe To Our Newsletter & Stay Updated